Phibro Animal Health (PAHC) Common Equity (2013 - 2026)

Phibro Animal Health's Common Equity history runs 14 years deep, the most recent figure standing at $361.8 million for Q1 2026.

• In Q1 2026, Common Equity rose 36.03% year-over-year to $361.8 million; the TTM figure through Mar 2026 stood at $361.8 million (up 36.03% YoY), while the FY2025 annual figure was $285.7 million, up 11.32% from the prior year.
• Common Equity was $361.8 million for Q1 2026 at Phibro Animal Health, up from $332.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $361.8 million in Q1 2026 to a low of $246.8 million in Q4 2024.
• Historically, Common Equity has averaged $279.3 million across 5 years, with a median of $270.1 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Common Equity dropped 9.16% in 2024, then jumped 36.03% in 2026.
• A 5-year view of Common Equity shows it stood at $268.4 million in 2022, then climbed by 0.91% to $270.8 million in 2023, then retreated by 8.86% to $246.8 million in 2024, then soared by 34.67% to $332.4 million in 2025, then grew by 8.87% to $361.8 million in 2026.
• The last three Common Equity figures came in at $361.8 million (Q1 2026), $332.4 million (Q4 2025), and $311.7 million (Q3 2025), per Business Quant data.